drugset / Trial / NCT01724242
Vaginal DHEA for Women After Breast Cancer
RandomizedParallel-groupQuadruple-blindTreatment
Summary
There does not appear to be a consensus regarding the treatment of vaginal dryness in women who have a contraindication to the use of estrogen products. DHEA, when used locally, may improve the symptoms of vaginal dryness due to its chemical properties.
Timeline
- Start
- 2013-02
- Primary completion
- 2014-01
- Completion
- 2014-12
Outcome
Outcome not reported
Stopped (Enrollment): “Inability to recruit patients”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DHEA | Unknown | 6.5 mg | Other |